文献速递流行病学与生物统计真实世界研究与卫生经济

有妊娠糖尿病史女性进展为2型糖尿病的系统综述与荟萃分析

Progression to type 2 diabetes in women with a known history of gestational diabetes: systematic review and meta-analysis.
PubMed 文献 · BMJ · 2020-05-13

该系统综述与荟萃分析纳入20项观察性研究,共1 332 373名女性(67 956例妊娠糖尿病(GDM)患者与1 264 417名对照),评估产后进展为2型糖尿病(T2DM)的风险。结果显示,有GDM史的女性发生T2DM的相对风险近乎是对照组的10倍(9.51,95%CI 7.14至12.67,P<0.001),不同种族亚组的累积发病率无统计学显著差异。

要点

  • 有GDM史的女性发生T2DM的相对风险为9.51(95%CI 7.14至12.67)。
  • 混合种族GDM人群T2DM累积发病率为16.46%(95%CI 16.16%至16.77%)。
  • 应重视产后早期干预以预防T2DM发生。

核心结论

  • 有GDM史的女性发生T2DM的风险近乎为血糖正常妊娠女性的10倍。
  • 该风险程度凸显了干预预防T2DM的重要性,尤其是产后早期。

研究设计与样本

  • 系统综述与荟萃分析,检索Medline和Embase 2000年1月至2019年12月的英文人类研究。
  • 纳入标准包括产后随访至少12个月、医生诊断的糖尿病、T2DM作为独立结局报告、且设有GDM组和对照组。
  • 共纳入20项观察性研究,合计1 332 373名个体(67 956例GDM女性与1 264 417名对照)。
  • 采用随机效应模型合并数据,以I2统计量评估异质性,并行亚组分析和meta回归。

主要发现

  • GDM组与对照组相比,T2DM发病的合并相对风险为9.51(95%CI 7.14至12.67,P<0.001)。
  • 混合种族GDM女性T2DM累积发病率为16.46%(95%CI 16.16%至16.77%)。
  • 以非白人为主的GDM人群T2DM累积发病率为15.58%(95%CI 13.30%至17.86%)。
  • 白人GDM人群T2DM累积发病率为9.91%(95%CI 9.39%至10.42%)。
  • 亚组间差异无统计学意义(白人与混合人群P=0.26;白人与非白人P=0.54)。

关键数值与推荐

  • GDM女性产后进展为T2DM的合并相对风险为9.51(95%CI 7.14至12.67)。
  • 混合种族GDM人群T2DM累积发病率为16.46%(95%CI 16.16%至16.77%)。
  • 以非白人为主GDM人群T2DM累积发病率为15.58%(95%CI 13.30%至17.86%)。
  • 白人GDM人群T2DM累积发病率为9.91%(95%CI 9.39%至10.42%)。

临床怎么用

  • 对有GDM史的女性应加强产后T2DM筛查与预防干预。
  • 干预重点应放在产后早期数年,以降低T2DM发病风险。

局限性

  • 研究间存在异质性,但预设亚组和meta回归未发现效应量与平均年龄、BMI、发表年份及随访时长显著相关。
  • 发表偏倚评估提示总体研究偏倚风险较低(P=0.58和P=0.90)。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

OBJECTIVE: To estimate and compare progression rates to type 2 diabetes mellitus (T2DM) in women with gestational diabetes mellitus (GDM) and healthy controls. DESIGN: Systematic review and meta-analysis. DATA SOURCES: Medline and Embase between January 2000 and December 2019, studies published in English and conducted on humans. ELIGIBILITY CRITERIA FOR SELECTING STUDIES: Observational studies investigating progression to T2DM. Inclusion criteria were postpartum follow-up for at least 12 months, incident physician based diagnosis of diabetes, T2DM reported as a separate outcome rather than combined with impaired fasting glucose or impaired glucose tolerance, and studies with both a group of patients with GDM and a control group. RESULTS: This meta-analysis of 20 studies assessed a total of 1 332 373 individuals (67 956 women with GDM and 1 264 417 controls). Data were pooled by random effects meta-analysis models, and heterogeneity was assessed by use of the I2 statistic. The pooled relative risk for the incidence of T2DM between participants with GDM and controls was estimated. Reasons for heterogeneity between studies were investigated by prespecified subgroup and meta-regression analyses. Publication bias was assessed by funnel plots and, overall, studies were deemed to have a low risk of bias (P=0.58 and P=0.90). The overall relative risk for T2DM was almost 10 times higher in women with previous GDM than in healthy controls (9.51, 95% confidence interval 7.14 to 12.67, P<0.001). In populations of women with previous GDM, the cumulative incidence of T2DM was 16.46% (95% confidence interval 16.16% to 16.77%) in women of mixed ethnicity, 15.58% (13.30% to 17.86%) in a predominantly non-white population, and 9.91% (9.39% to 10.42%) in a white population. These differences were not statistically significant between subgroups (white v mixed populations, P=0.26; white v non-white populations, P=0.54). Meta-regression analyses showed that the study effect size was not significantly associated with mean study age, body mass index, publication year, and length of follow-up. CONCLUSIONS: Women with a history of GDM appear to have a nearly 10-fold higher risk of developing T2DM than those with a normoglycaemic pregnancy. The magnitude of this risk highlights the importance of intervening to prevent the onset of T2DM, particularly in the early years after pregnancy. SYSTEMATIC REVIEW REGISTRATION: PROSPERO CRD42019123079.

来源:BMJ,查看原文。版权归原作者所有。

引用

  1. Vounzoulaki E, Khunti K, Abner SC, et al. Progression to type 2 diabetes in women with a known history of gestational diabetes: systematic review and meta-analysis. BMJ. 2020. PMID: 32404325. doi:10.1136/bmj.m1361

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。